Reverse anticoagulation
For life threatening intracranial bleeding, reverse anticoagulation rapidly.
Warfarin
Give:
4 factor prothrombin complex concentrate according to INR and body weight
plus:
Vitamin K 10 mg IV
Dabigatran
Use:
Idarucizumab 5 g IV
Apixaban or rivaroxaban
Use:
Andexanet alfa where available and appropriate, or 4 factor PCC according to institutional emergency reversal protocol.
Do not delay life saving surgery waiting for complete laboratory normalisation when reversal has been initiated and neurological deterioration is ongoing.
Surgical thresholds
Evacuate an acute SDH when:
- Thickness is greater than 10 mm
or
- Midline shift is greater than 5 mm
regardless of GCS.
A comatose patient with:
- GCS below 9
- SDH thickness below 10 mm
- Shift below 5 mm
still requires surgery when one or more of the following occur:
- GCS has fallen by at least 2 points
- New asymmetric or fixed dilated pupils
- ICP is persistently elevated.
Severe TBI patients with acute SDH and coma require ICP focused monitoring and treatment.
Procedure
Perform a large trauma craniotomy.
Evacuate clot.
Control:
- Cortical bleeding
- Bridging veins where accessible
- Contused bleeding surfaces
Inspect for significant underlying parenchymal injury.
If the brain remains swollen beyond the inner table or ICP remains dangerously high, leave the bone flap off and perform decompressive craniectomy with duraplasty.
The decompression should be large rather than a small restrictive window.
Nonoperative management
A small SDH without significant shift or neurological deficit can be observed with:
- Frequent examination
- Repeat CT
- Correction of coagulopathy
- ICP surveillance in severe injury
Any deterioration requires immediate reassessment.
Seizures
Use 7 day early seizure prophylaxis in significant acute SDH unless there is a specific contraindication.
Do not continue prophylaxis long term unless a seizure occurs or another indication develops.